Abstract:SARS-CoV-2 infection causes a variety of clinical manifestations, many of which originate from altered immune responses, either locally or systemically. Immune cell crosstalk occurs mainly in lymphoid organs. However, systemic cell interaction specific to COVID-19 has not been well characterized. Here, by employing single cell RNA sequencing and imaging flow cytometry analysis, we unraveled, in peripheral blood, a heterogeneous group of cell complexes formed by the adherence of CD14+ monocytes to different cytotoxic lymphocytes, including SARS-CoV-2-specific CD8+ T cells, γδT and NKT cells. These lymphocytes attached to CD14+ monocytes that showing enhanced inflammasome activation and pyroptosis-induced cell death in progression stage, whereas in convalescent phase, CD14+ monocytes with elevated antigen presentation potential were targeted by cytotoxic lymphocytes, thereby restricting the excessive immune activation. Collectively, our study reports previously unrecognized cell-cell interplay in SARS-CoV-2 specific immune response, providing new insight into the intricacy of dynamic immune cell interaction representing anti-viral defense.

What problem does this paper attempt to address?

The paper primarily explores a novel pattern of intercellular interactions in COVID-19 patients, particularly focusing on the role of cytotoxic lymphocytes (including SARS-CoV-2-specific CD8+ T cells, γδT cells, and NKT cells) and monocyte-formed complexes (CLM) in systemic immune responses. ### Research Background - SARS-CoV-2 infection leads to various clinical manifestations, most of which stem from changes in local or systemic immune responses. - Interactions between immune cells mainly occur in lymphoid organs, but COVID-19-specific systemic cellular interactions have not been fully described. ### Main Findings 1. **Discovery of Cell Complexes**: Through single-cell RNA sequencing and imaging flow cytometry analysis, a heterogeneous cell complex composed of CD14+ monocytes and different types of cytotoxic lymphocytes (such as SARS-CoV-2-specific CD8+ T cells) was found in peripheral blood. 2. **Characteristics During Disease Progression**: During the disease progression stage, these cytotoxic lymphocytes attach to CD14+ monocytes, exhibiting enhanced inflammasome activation and pyroptosis pathways leading to cell death. 3. **Changes During Recovery**: In the recovery phase, the interaction between cytotoxic lymphocytes and CD14+ monocytes limits excessive immune activation, with CD14+ monocytes showing increased antigen-presenting capabilities. 4. **Molecular Mechanisms**: The study also revealed the molecular characteristics of CLM during disease progression, including upregulation of inflammasome assembly and pathways related to viral genome replication; during the recovery phase, enhanced MHC-II complex assembly and upregulation of apoptosis-related genes were observed. ### Conclusion This study is the first to report the existence and potential role of cytotoxic lymphocyte-monocyte complexes in SARS-CoV-2-specific immune responses, providing new insights into the pathogenesis of COVID-19 and the development of effective therapeutic strategies. Particularly, the different functional characteristics of these intercellular interactions at various stages of the disease are crucial for maintaining immune system balance.

Cytotoxic lymphocyte-monocyte complex reflects the dynamics of COVID-19 systemic immune response

Cytotoxic Lymphocyte-Monocyte Complex Reflects the Dynamics of Coronavirus Disease 2019 Systemic Immune Response

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Single-cell landscape of immunological responses in patients with COVID-19

High-dimensional single-cell analysis reveals the immune characteristics of COVID-19

Dynamic blood single-cell immune responses in patients with COVID-19

Interplay of Monocytes and T Lymphocytes in COVID-19 Severity

Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19

Single-cell RNA-seq and V(D)J profiling of immune cells in COVID-19 patients

The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing

Single-cell landscape of immunological responses in COVID-19 patients

Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Identification of Distinct Immune Cells Associated with Various Clinical Presentations of COVID-19

Analysis of the Dynamic Relationship Between Immune Profiles and the Clinical Features of Patients with COVID-19

Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients

Dynamic Response Landscape of Immune Cells Identified Immune Dysfunction Which Predicts Disease Progression in COVID-19 Infected Patients.

A Landscape Study on COVID-19 Immunity at the Single-Cell Level

Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients

Analysis of Peripheral Blood T Cell Receptor and B Cell Receptor Repertoires Reveals Dynamic Adaptive Immune Responses in COVID-19 Patients